EFTR

eFFECTOR Therapeutics, Inc. Common Stock
EFTR

Overview Fund Activity
Delisted

EFTR was delisted on the 2nd of July, 2024.

Back to rankings

27 hedge funds and large institutions have $13.6M invested in eFFECTOR Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
27
Holders Change
+3
Holders Change %
+12.5%
% of All Funds
0.47%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
6
Increased
5
Reduced
2
Closed
3
Calls
$57K
Puts
–
Net Calls
+$57K
Net Calls Change
-$85K

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$112K
2
WFAG
2
Wescott Financial Advisory Group
Pennsylvania
$32K
3
Two Sigma Investments
3
Two Sigma Investments
New York
$27K
4
TSS
4
Two Sigma Securities
New York
$9K
5
UBS Group
5
UBS Group
Switzerland
$9K

Top Sellers

1
Norges Bank
1
Norges Bank
Norway
$0
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$245K
3
VF
3
Virtu Financial
New York
$0
4
PCM
4
Penserra Capital Management
California
$0
5
Morgan Stanley
5
Morgan Stanley
New York
$3K
Name Holding Trade Value Shares
Change 		Shares
Change %
MOS
26
MGO One Seven
Ohio
$11 +$11 +803 New
Norges Bank
27
Norges Bank
Norway
– -$591K -16,652 Closed
VF
28
Virtu Financial
New York
– -$22K -627 Closed
PCM
29
Penserra Capital Management
California
– -$7K -204 Closed
1
2